MedTrace Logo

REAl World Dementia OUTcomes: Observational Study

NCT07238049 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 3165

Last updated 2025-11-20

No results posted yet for this study

Summary

READ-OUT observational study will investigate blood-based biomarkers for dementia in real-world clinical settings. This 3-year observational study will include 3165 people, males or females aged 45 years or older, with cognitive impairment of any severity.

Participants provide blood samples and complete questionnaires about quality of life and healthcare use, with some having additional follow-ups at 2 weeks and 1 year. The study will assess reliability and accuracy of blood tests in diagnosing dementia.

Conditions

  • Alzheimer Disease (AD)
  • Mild Cognitive Impairment (MCI)
  • Dementia

Sponsors & Collaborators

  • University of Cambridge

    collaborator OTHER

  • University of Edinburgh

    collaborator OTHER

  • Greater Manchester Mental Health NHS Foundation Trust

    collaborator OTHER

  • University of Bristol

    collaborator OTHER

  • Queen Mary University of London

    collaborator OTHER

  • West London NHS Trust

    collaborator OTHER

  • University College, London

    collaborator OTHER

  • Imperial College London

    collaborator OTHER

  • Aneurin Bevan University Health Board

    collaborator OTHER

  • Queen's University, Belfast

    collaborator OTHER

  • University of Oxford

    lead OTHER

Principal Investigators

  • Vanessa Raymont · University of Oxford

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2029-10-31
Completion
2029-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07238049 on ClinicalTrials.gov